Request for electron microscope
索取电子显微镜
基本信息
- 批准号:7792771
- 负责人:
- 金额:$ 19.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimal Disease ModelsAreaAutophagocytosisCell Membrane PermeabilityCommunitiesDemyelinationsDiseaseElectron MicroscopeElectron MicroscopyGeneral HospitalsHuntington DiseaseInstitutionMassachusettsNervous system structureNeurodegenerative DisordersNeurologyNeuronsNeurotransmitter ReceptorParkinson DiseaseProteinsRecordsRecyclingResearchResearch PersonnelRoleTrainingTraumatic Brain InjuryWorkdigital imagingimprovedinstrumenttransmission process
项目摘要
DESCRIPTION (provided by applicant): This is a re-submission application for a request for a new transmission electron microscope (TEM) to replace an existing one that was purchased in 1979. Our current TEM has been operating for 28 years. It is failing and is wholly inadequate to serve the research needs of our large active and expanding research community in the Department of Neurology at Massachusetts General Hospital. Many of our researchers work in neurodegenerative diseases including Alzheimer disease, Huntington's disease, and Parkinson's disease. Some of the current exciting topics we work on include the role of autophagy in clearance of disease proteins from neurons, the effects of disease proteins on organization and recycling of neurotransmitter receptors in animal models of disease, membrane permeability changes in traumatic brain injury, and the mechanisms underlying axonal demyelination. These and other research areas will be greatly enhanced by having a new TEM in our department. Some of us have long track records in using electron microscopy to study the nervous system. The lack of a reliably functioning TEM hinders our ability to plan new directions involving EM analysis and in training our young investigators in EM applications. Advances in TEMs have greatly improved especially in capability for self-alignment and digital imaging, which we lack in our TEM. We do not have access to other modern instruments at our institution. Since the first submission, I have received an institutional commitment of $141,000 to be used toward the purchase of a new TEM. We have also improved our application by making the recommended revisions suggested by the reviewers.
描述(由申请人提供):这是一份重新提交的申请,要求购买新的透射电子显微镜(TEM)以取代1979年购买的现有电子显微镜。我们目前的瞬变显微镜已经运行了28年。它是失败的,完全不足以满足我们在马萨诸塞州综合医院神经内科的庞大、活跃和不断扩大的研究社区的研究需求。我们的许多研究人员从事神经退行性疾病的研究,包括阿尔茨海默病、亨廷顿病和帕金森氏病。目前我们致力于的一些激动人心的主题包括自噬在清除神经元中的疾病蛋白中的作用,疾病蛋白对疾病动物模型中神经递质受体的组织和循环的影响,创伤性脑损伤中的膜通透性变化,以及轴突脱髓鞘的机制。这些和其他研究领域将大大加强,因为我们系有一个新的瞬变电磁波。我们中的一些人在使用电子显微镜研究神经系统方面有着长期的记录。缺乏可靠运行的瞬变电磁法阻碍了我们规划涉及EM分析的新方向的能力,以及在EM应用方面培训我们的年轻研究人员的能力。电子显微镜的进步已经大大提高,特别是在自对准和数字成像能力方面,这是我们的电子显微镜所缺乏的。在我们的机构中,我们无法获得其他现代工具。自从第一次提交以来,我已经收到了一笔141,000美元的机构承诺,将用于购买新的TEM机。我们还改进了我们的应用程序,根据评审员的建议进行了修改。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model.
早期全身突变亨廷顿蛋白降低可避免蛋白质和脂质的变化,这对 LacQ140 小鼠模型中的突触功能和白质维持很重要。
- DOI:10.1101/2023.01.26.525697
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Shing,Kai;Sapp,Ellen;Boudi,Adel;Liu,Sophia;Seeley,Connor;Marchionini,Deanna;DiFiglia,Marian;Kegel-Gleason,KimberlyB
- 通讯作者:Kegel-Gleason,KimberlyB
Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington's Disease Mouse Striatum.
- DOI:10.3389/fnsyn.2021.618391
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Iuliano M;Seeley C;Sapp E;Jones EL;Martin C;Li X;DiFiglia M;Kegel-Gleason KB
- 通讯作者:Kegel-Gleason KB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marian DiFiglia其他文献
Marian DiFiglia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marian DiFiglia', 18)}}的其他基金
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 19.42万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 19.42万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 19.42万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 19.42万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 19.42万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 19.42万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 19.42万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 19.42万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 19.42万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 19.42万 - 项目类别:














{{item.name}}会员




